About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Surveillance Study of NovoRapid® for New Drug Re-examination

Surveillance Study of NovoRapid® for New Drug Re-examination

NCT01490112·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novo Nordisk A/S

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subjects with diabetes mellitus (type 1, type 2, or gestational) prescribed with insulin aspart (NovoRapid®)

The record

StatusCompleted

PhaseNo phase

Taking part1,239

StartedJan 2005

UpdatedOct 28, 2016

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Where1

Novo Nordisk Investigational Site
Seoul, South Korea